Search
Genenta Science SPA
GNTAAdd to Watchlist
1.310USD
+0.010+0.77%
Close 08-14 16:00（ET）Quotes delayed by 15 min
30.70MMarket Cap
LossP/E TTM
More Details of Genenta Science SPA Company
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Genenta Science SPA Profile
Ticker SymbolGNTA
Company nameGenenta Science SPA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Number of employees13
Security typeDepository Receipt
Fiscal year-endDec 15
AddressVia Olgettina 58
CityMILANO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryItaly
Postal code20132
Phone
Websitehttps://www.genenta.com/
Ticker SymbolGNTA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Company Executives of Genenta Science SPA
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
FAQs
Who are the top five shareholders of Genenta Science SPA?
The top five shareholders of Genenta Science SPA are: Mr. Pierluigi Paracchi
How many institutions hold shares of Genenta Science SPA (GNTA)?
As of 2026Q1, 24 institutions hold shares of Genenta Science SPA, with a combined market value of approximately 3.34M, accounting for 14.15% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1015532.00.